jamunjar-logo
whatsapp
cartmembermenu

Fibrinogen

Unit Test
image

Report in 16Hrs

image

At Home

nofastingrequire

No Fasting Required

Details

Soluble glycoprotein produced by the liver that plays a central role in blood clot formation.Increasing in response to inflammation, infection, or tissue injury.

1,2751,550

18% OFF

Fibrinogen Test Information Guide

  • Fibrinogen
    • Why is it done?
      • Measures the level of fibrinogen, a protein produced by the liver that plays a critical role in blood clotting and wound healing
      • Assess bleeding and clotting disorders, including unexplained bleeding, easy bruising, or prolonged bleeding after injury or surgery
      • Evaluate patients with disseminated intravascular coagulation (DIC), a serious condition where blood clots form throughout the body
      • Monitor liver function, as the liver produces fibrinogen and abnormal levels may indicate liver disease
      • Assess cardiovascular disease risk, as elevated fibrinogen is associated with increased risk of heart attack and stroke
      • Evaluate abnormal bleeding during surgical procedures or after trauma
      • Typically performed as part of a coagulation panel or when specific bleeding/clotting concerns are identified
    • Normal Range
      • Reference Range: 200-400 mg/dL (milligrams per deciliter) or 2.0-4.0 g/L (grams per liter)
      • Normal Result: Fibrinogen levels within the normal range indicate adequate clotting ability and proper liver function. Normal levels suggest a reduced risk of bleeding complications.
      • Low Fibrinogen (<200 mg/dL): May indicate increased bleeding risk, liver disease, DIC, or inherited fibrinogen deficiency
      • High Fibrinogen (>400 mg/dL): May indicate increased risk of thrombosis (blood clots), inflammation, acute phase response to infection or stress, or cardiovascular disease risk
      • Units of Measurement: mg/dL or g/L (both represent the concentration of fibrinogen in blood)
      • Important Note: Reference ranges may vary slightly between laboratories depending on methodology and population studied
    • Interpretation
      • Low Fibrinogen Levels (<100 mg/dL - Severe):
        • Significant bleeding risk; may require fibrinogen replacement
        • Associated with DIC, liver cirrhosis, congenital afibrinogenemia, or antifibrinolytic therapy
      • Mildly Low Fibrinogen (100-200 mg/dL):
        • Increased bleeding risk, particularly with trauma or surgery
        • May indicate mild liver dysfunction or consumption from prolonged bleeding
      • Elevated Fibrinogen Levels (>400 mg/dL):
        • Increases blood viscosity and clotting tendency; elevated risk for thrombosis
        • Associated with acute inflammation, infection, myocardial infarction, stroke, and cardiovascular disease
        • Can be associated with smoking, obesity, diabetes, and chronic inflammatory conditions
      • Factors Affecting Fibrinogen Levels:
        • Pregnancy: Levels naturally increase during pregnancy
        • Smoking: Increases fibrinogen levels
        • Oral Contraceptives: May increase fibrinogen levels
        • Estrogen Therapy: Can elevate levels
        • Age: May increase slightly with age
        • Inflammation and Infection: Acute phase proteins increase fibrinogen as part of stress response
    • Associated Organs
      • Primary Organ System:
        • Liver: Primary site of fibrinogen synthesis; liver disease directly affects fibrinogen production
        • Blood/Hemostatic System: Fibrinogen is a critical factor in blood clotting cascade
      • Conditions Associated with Abnormal Fibrinogen:
        • Liver Disease: Cirrhosis, hepatitis, liver failure cause low fibrinogen
        • Disseminated Intravascular Coagulation (DIC): Life-threatening condition with dangerously low fibrinogen
        • Inherited Fibrinogen Deficiencies: Afibrinogenemia, hypofibrinogenemia, dysfibrinogenemia
        • Cardiovascular Disease: High fibrinogen increases risk of coronary artery disease, myocardial infarction, and stroke
        • Thrombotic Disorders: Deep vein thrombosis, pulmonary embolism associated with elevated fibrinogen
        • Acute Infection/Inflammation: Sepsis, pneumonia, acute phase response increases fibrinogen
        • Cancer: Elevated fibrinogen common in malignancies
      • Potential Complications:
        • Low fibrinogen: Excessive bleeding, hemorrhage, transfusion requirements
        • High fibrinogen: Thrombosis, stroke, myocardial infarction, organ damage from clotting
    • Follow-up Tests
      • If Low Fibrinogen (<200 mg/dL):
        • Prothrombin Time (PT) and Activated Partial Thromboplastin Time (aPTT) to assess overall clotting function
        • Thrombin Time (TT) to evaluate fibrin formation
        • Fibrin Degradation Products (FDP) and D-dimer to assess for DIC
        • Liver Function Tests (AST, ALT, bilirubin, albumin) to evaluate hepatic function
        • Platelet count and peripheral blood smear
      • If High Fibrinogen (>400 mg/dL):
        • C-Reactive Protein (CRP) to assess for inflammation
        • Erythrocyte Sedimentation Rate (ESR) to assess for inflammatory conditions
        • Lipid Panel and metabolic markers for cardiovascular risk assessment
        • Troponin and BNP if myocardial infarction or heart failure suspected
        • Blood glucose and hemoglobin A1C to assess for diabetes
      • Imaging and Additional Testing:
        • Ultrasound of the liver if liver disease suspected
        • ECG and stress testing for cardiovascular evaluation
        • CT scan if thrombosis or malignancy suspected
      • Monitoring Frequency:
        • DIC patients: Repeat fibrinogen testing every 6-24 hours initially during acute phase
        • Liver disease monitoring: Periodic testing as recommended by hepatologist, typically monthly to quarterly
        • Cardiovascular risk patients: Annual or biennial testing as part of cardiovascular risk assessment
    • Fasting Required?
      • Fasting Requirement: No
      • Special Preparations Required:
        • No fasting is necessary for fibrinogen testing; blood can be drawn at any time of day
        • No dietary restrictions apply to this test
      • Medications:
        • Continue taking all regularly prescribed medications unless specifically instructed otherwise
        • Anticoagulants (warfarin, heparin) and antiplatelet agents (aspirin, clopidogrel) should not be stopped unless directed by physician, as they may affect results
        • Inform the laboratory of all current medications as some may influence fibrinogen levels
      • General Patient Preparation:
        • Standard venipuncture; no special preparation beyond routine blood draw
        • Inform phlebotomist of any difficulty with needle puncture or tendency to bruise easily
        • Blood should be drawn into proper collection tubes with citrate (usually light blue-top tube)
        • Sample should be processed and tested within appropriate timeframe (typically within 4 hours) to ensure accuracy

How our test process works!

customers
customers